Health ❯ Medicine

Patient Care

Quality of Life Treatment Options Post-Operative Care Treatment Outcomes Treatment Efficacy Medication Adherence Cancer Treatment Personalized Medicine Rehabilitation Cancer Patients Post-Operative Recovery Recovery Infections Prescription Access Surgery Volunteers in Research Cancer Treatment Strategies Treatment Adherence Diagnosis Adverse Effects Risk Reduction Treatment Protocols Counseling Safety Profile Clinical Case Studies Socioeconomic Factors Degenerative Diseases Side Effects Underrepresented Populations Survival Rates Symptom Management Home Treatment Medication Management Post-Transplant Care Case Studies Transplant Recipient Care Cancer Screening Family Impact Life Expectancy Treatment Resistance Nutritional Recommendations Patient Experience Medication Discontinuation

Daraxonrasib Doubles Survival in Phase 3 Trial of Treated Metastatic Pancreatic Cancer

An oral KRAS inhibitor that raised median survival to 13.2 months is now available through an FDA expanded access program pending formal review

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Real-World Study Finds Tezepelumab Cuts Severe Asthma Flares by 70% Across Diverse Patients

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Regeneron’s Garetosmab Slashes New Bone Lesions in FOP Phase 3, U.S. Filing Planned This Year

Study Links THC in Ovarian Follicles to Lower Rate of Normal Embryos in IVF

Liraglutide Cuts Chronic Migraine Days by More Than Half

Long-Term Desogestrel Use Linked to Slight Rise in Brain Tumor Risk

JM2 Peptide Disrupts Glioblastoma Stem Cells and Slows Tumor Growth in Preclinical Models

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications